Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Combined Pioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Diabetic Patients With Ischemic Stroke
NCT04419337Phase 2Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Sep 2019
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in ischemic stroke, type 2 diabetes mellitus (T2DM), sponsored by Chang Gung Memorial Hospital. Status: unknown.
02
Drugs
pioglitazone
03
Conditions
ischemic stroketype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04419337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04419337.